Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity

Matteo Bruschettini*, Petter Brattström, Chiara Russo, Wes Onland, Peter G. Davis, Roger Soll

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To determine the effects of higher versus standard doses of caffeine on mortality and major neurodevelopmental disability in preterm infants with (or at risk of) apnea, and preterm infants peri-extubation. To determine the effects of early versus late discontinuation of caffeine administration on mortality and major neurodevelopmental disability in preterm infants with (or at risk of) apnea, and preterm infants peri-extubation.
Original languageEnglish
Article numberCD013873
JournalCochrane Database of Systematic Reviews
Volume2021
Issue number2
DOIs
Publication statusPublished - 18 Feb 2021
Externally publishedYes

Cite this